In its recent settlement with pharmaceutical company kaléo, Inc., the Department of Justice foreshadowed that it also would be pursuing cases against specialty pharmacies that sold and dispensed Evzio, a kaléo drug. Evzio, a naloxone anti-overdose auto-injector, cost over $4000, while Narcan, which was approved for the same purpose, cost only about...
Continue reading…
Tag: kickbacks
Appeals Court Affirms All Convictions of Insys Executives
Today, the First Circuit affirmed all of the convictions of the executives of Insys, the manufacturer of a highly-addictive sublingual fentanyl spray that the FDA had approved only to treat breakthrough cancer pain. Congratulations to Assistant United States Attorneys Nat Yeager and David Lazarus for successfully leading perhaps the most important pharma...
Continue reading…
Info tech company Practice Fusion pays $145 million to settle charges it set up electronic records system getting docs to prescribe opioids
A San Francisco-based health information technology company will pay $145 million to resolve criminal and civil charges that it helped set up an electronic health records system that encouraged physicians to prescribe opioids to patients who might not need them, federal prosecutors in Vermont said Monday.
Vermont U.S....
Continue reading…
Durable medical equipment maker Resmed to pay #37.5 million for paying kickbacks to DME suppliers, sleep labs and others
ResMed Corp., a manufacturer of durable medical equipment (DME) based in San Diego, California, has agreed to pay more than $37.5 million to resolve alleged False Claims Act violations for paying kickbacks to DME suppliers, sleep labs and other health care providers, the Department of...
Continue reading…
Framingham Massachusetts Lab pays $26.67 Million to resolve allegations of payment kickbacks for patient referrals and improper billing
Laboratory Boston Heart Diagnostics Corporation (Boston Heart), of Framingham, Massachusetts, has agreed to pay $26.67 million to resolve False Claims Act allegations involving payments for patient referrals in violation of the Anti-Kickback Statute and the Stark Law, as well as claims otherwise improperly billed to federal healthcare programs for laboratory testing, the Department of...
Continue reading…
